Teva slumps as Trump turns attention to generic drug prices

Teva Photo: Sivan Faraj
Teva Photo: Sivan Faraj

The US president has ordered his staff to prepare an order lowering prescription drug prices in the US.

In the 2016 US presidential campaign, it was Democratic Party candidate Hilary Clinton who aroused concern about restrictions on drug prices in the US. This pushed down the share prices of pharma sector companies on the Tel Aviv Stock Exchange (TASE), but it is now the election winner, President Donald Trump, who is taking matters a step further by advocating a reference index for drug prices, as is the practice in many European countries.

Late last week, Trump ordered US administration officeholders to prepare an order to reduce the prices paid for drugs in the US to the level of prices in countries where they are the cheapest in the world. "Why do other nations like Canada pay less than us," Trump asked rhetorically. At the same time, there are developing countries with a very low GDP, so these probably cannot be used as a reference sample. The report nevertheless resulted in tumult that dragged down share prices in the sector.

In additional bad news for the pharma sector, Democrats in Congress aiming at transparency in drug prices and lower costs for consumers are likely to support Trump's measures.

Trump tweeted on Twitter on Sunday, "Last year was the first in 51 years in which prescription drug prices actually went down, but things have been, and are being, put in place that will drive them down substantially."

Drug prices are a large expense in US health budgets. According to figures from the US Department of Health and Human Services, drugs account for 17% of the cost of the US health system. People in the US pay double or more for drugs than consumers in other countries. A 2015 Reuters survey of the 20 bestselling prescription drugs in the US found that they were an average of three times as expensive as in the UK, more expensive than in any other European market, six times as expensive as in Brazil, and 16 times as expensive as in India. Trump wants to change this.

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) share price is down 5.75% on the TASE, following a 3% drop on Wall Street yesterday. Perrigo Company (NYSE:PRGO; TASE:PRGO) is off 2.41%.

Trump's order is a further blow to battered Teva, which is facing a decline in sales of Copaxone, its former flagship drug, and two major lawsuits, involving allegedly fixing the prices of drugs and selling addictive opioids.  

Published by Globes, Israel business news - en.globes.co.il - on July 9, 2019

© Copyright of Globes Publisher Itonut (1983) Ltd. 2019

Teva Photo: Sivan Faraj
Teva Photo: Sivan Faraj
Infinity Tower Tel Aviv credit: Courtesy Hagag Group French investors buy 2 Tel Aviv apartments for NIS 27.5m

The two apartments are in Hagag Group's Infinity Tower in the Summeil district.

El Al plane credit: Shutterstock El Al receives state approval to distribute dividend

The Israeli airline has now announced that it will be able to distribute up to 30% of net profit in 2025 and up to 40% in 2026-2028.

Relocation credit: Michal Raz-Haimovitz How to turn the tech relocation tide

With thousands of tech employees leaving Israel, the Innovation Authority proposes measures that could reverse the trend.

groundcover founders credit: Yossi Yarom Israeli observability co groundcover raises $35m

groundcover has developed a “Bring Your Own Cloud” (BYOC) observability solution, redefining the architecture of a modern observability platform.

Tel Aviv Stock Exchange credit: Shutterstock MagioreStock Foreign investment in TASE hits five-year high

Foreign investors have been flocking to the Tel Aviv Stock Exchange in recent weeks, the TASE research department tells "Globes."

Elbit Systems tank turret systems credit: Elbit Systems Elbit Systems wins $100m tank turret systems deal

The Israel defense electronics company will supply its advanced UT30 MK2 unmanned turret systems to General Dynamics European Land Systems (GDELS) to be supplied to a NATO European country.

Tomer Weingarten Photo: PR Trump targets SentinelOne exec in act of revenge

The US administration has suspended the security clearance of the company's chef intelligence and public policy officer Chris Krebs and everyone associated with him.

Tel Aviv Stock Exchange share prices rising credit: Tali Bogdanovsky TASE opens sharply higher after Trump U-turn on tariffs

The pause is being interpreted as a climb down after US President Donald Trump admitted he had made the move to calm the markets.

Ashot Ashkelon credit: Ministry of Defense Up 250%, Ashot Ashkelon wins another Defense Ministry order

The Israeli defense company's share price has risen 250% in the past three years since FIMI Opportunity Funds acquired control.

Liad Agmon credit: Eyal Izhar Insight Partners Liad Agmon steps down as managing partner

Serial entrepreneur Agmon has served as a partner at Insight Partners Israel alongside Daniel Aronovitz who set up the Israel office.

Shekels credit: Shutterstock Vladerina32 Shekel slide resumes amid escalating tariff war

The Bank of Israel is not expected to intervene in the forex market despite the sharp depreciation of the shekel.

Nir Zuk credit: Inbal Marmari Palo Alto Networks mulls buying AI security co for $700m

Sources inform "Globes" that on Palo Alto's radar is Protect AI.

President Donald Trump hosts Prime Minister Benjamin Netanyahu credit: Reuters Kevin Mohatt Israeli officials confident on US tariff concessions

Senior Israeli figures believe that concessions could be tied to progress on strategic regional political issues that are important to President Trump.

Phoenix Investment House CEO Avner Hadad  credit: Tommy Harpaz "The market has priced in all the bad things"

Phoenix Investment House CEO Avner Hadad says US markets could continue to fall, but that we are close to interesting territory for patient investors.

Tel Aviv credit: Shutterstock Tel Aviv slips in World's Wealthiest Cities ranking

Tel Aviv's position as one of the world's wealthiest cities took a big knock over the past year as it slipped from 42nd to 48th in investment advisors Henley & Co.'s "World's Wealthiest Cities" Top 50 ranking.

Leviathan platform  credit: Albatross C'ttee seen recommending no cut in gas exports

The Dayan committee on the future of the gas sector estimates that Israel's natural gas reserves will run out in 2045.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018